We are monitoring the impact of COVID-19 on Europe Apheresis Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 2962
Share on
Share on

Europe Apheresis Market Research Report - Segmented By Product, Procedure, Application, Technology, End-User & Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe) - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2020 to 2025)

Pulished: February, 2020
ID: 2962
Pages: 155

Europe Apheresis Market Size (2020 to 2025)

The size of the Apheresis Market worth in Europe was valued at USD 0.46 billion in 2020 and estimated to be growing at a CAGR of 8.74% to reach USD 0.7 billion by 2025.

Y-O-Y growth in the incidence of blood disorders such as bleeding disorders and a decrease in platelet count are expected to hike the European Apheresis Market's growth. The growing prevalence of chronic diseases such as cancer and autoimmune diseases, an increasing number of organ donors when needed, further adds fuel to the market's growth rate. Perforation in the occurrence rate of chronic diseases, increasing necessity for source plasma, mounting activities considering the blood safety and growing number of complicated surgical processes, and acceptance of reimbursement policies are projected to lavish the market's need from 2020 to 2025.

Shortage of capable donors, the high costs associated with the apheresis devices, expensiveness involved with the maintenance and installation of these devices are expected to hinder the market growth to a small extent.

This research report on the European Apheresis Market has been segmented and sub-segmented into the following categories:

By Product:

  • Devices
  • Disposables

By Procedure:

  • Donor
  • Therapeutic
  • Photopheresis

By Application:

  • Renal Diseases
  • Neurology
  • Cancer
  • Hematology
  • Autoimmune Diseases
  • Cardiovascular Diseases

By Technology:

  • Centrifuge
  • Membrane Separation

By End User:

  • Private Blood Collection Centres
  • Public Blood Collection Centres
  • Hospitals

By Country: 

  • UK
  • France
  • Spain
  • Germany
  • Italy
  • Russia
  • Sweden
  • Denmark
  • Switzerland
  • Netherlands
  • Turkey
  • Czech Republic
  • Rest of Europe

Regional Analysis:

In Europe, Germany leads the Apheresis market, followed by France and U.K. The market in this region is projected to grow strongly during the forecast period due to various factors such as growing awareness about Apheresis, financial strength to procure expensive tools, and favorable reimbursement policies. The European market has a share of 26% Global market. It has a CAGR of 8.74% owing to the presence of less stringent apheresis devices approval regulations and availability of massive untapped opportunities in emerging European countries.

The German apheresis market is anticipated to rule the European market during the forecast period owing to increasing consciousness regarding apheresis and economic strength to obtain high-priced devices. The escalating number of blood donations uses the apheresis devices, and augmenting the number of apheresis therapy procedures is predicted to drive Germany's market. The growing requirement for apheresis that can affect the lesser pathogens in platelets and components to reduce the threat of transfer-transmitted infections is further estimated to favor Germany's market.

France's apheresis market is expected to be another lucrative region in the European market and is anticipated to grow with a CAGR of 12.5% from 2020 to 2025. The rise in healthcare expenses, a huge patient population with a large transmission requirement, is majorly supporting the French market.

The UK market is the third leading country in the European market and is expected to grow at a brisk pace during the forecast period due to technological advancements.

Key players operating in the Europe Apheresis Market profiled in this report are Asahi Kasei Medical Co., Ltd., Haemonetics Corporation, Terumo BCT, Inc., Fresenius Medical Care, Kawasumi Laboratories Inc., Cerus Corporation, HemaCare Corporation, Kaneka Corporation, B. Braun Melsungen AG, and Nikkiso Co., Ltd., Therakos, Inc., and Medica S.p.A.

1. Introduction         

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods  

                1.4 General Study Assumptions                

2. Research Methodology                   

                2.1 Introduction       

                2.2 Research Phases                      

        2.2.1 Secondary Research           

        2.2.2 Primary Research 

        2.2.3 Econometric Modelling      

        2.2.4 Expert Validation  

                2.3 Analysis Design 

                2.4 Study Timeline  

3. Overview               

                3.1 Executive Summary                

                3.2 Key Inferences 

                3.3 Epidemology      

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)            

                4.1 Market Drivers  

                4.2 Market Restraints                    

                4.3 Key Challenges 

                4.4 Current Opportunities in the Market      

5. Market Segmentation                      

                5.1 Product

        5.1.1 Introduction           

        5.1.2 Apheresis devices

                        5.1.2.1 Plasma separators

                        5.1.2.2 Plasma component separators

                        5.1.2.3 Immunoadsorption Columns

                        5.1.2.4 Plasma Perfusion Columns

                        5.1.2.5 Hemoperfusion Columns

        5.1.3 Apheresis disposables       

        5.1.4  Y-o-Y Growth Analysis, By Product              

        5.1.5  Market Attractiveness Analysis, By Product            

        5.1.6  Market Share Analysis, By Product              

                5.2 Procedure                   

        5.2.1 Introduction           

        5.2.2 Donor Apheresis  

        5.2.3 Therapeutic Apheresis       

        5.2.4 Y-o-Y Growth Analysis, By Procedure          

        5.2.5 Market Attractiveness Analysis, By Procedure        

        5.2.6 Market Share Analysis, By Procedure          

                5.3 Application                 

        5.3.1 Introduction           

        5.3.2 Renal Diseases      

        5.3.3 Neurology               

        5.3.4 Cancer      

        5.3.5 Hematology            

        5.3.6 Autoimmune Diseases       

        5.3.7 Cardiovascular Diseases    

        5.3.8 Y-o-Y Growth Analysis, By Application         

        5.3.9 Market Attractiveness Analysis, By Application       

        5.3.10 Market Share Analysis, By Application      

                5.4 Technology                 

        5.4.1 Centrifugation       

                        5.4.1.1 Intermittent Flow

                        5.4.1.2 Continuous Flow

        5.4.2 Membrane Separation      

        5.4.3 Y-o-Y Growth Analysis, By Technology        

        5.4.4  Market Attractiveness Analysis, By Technology     

        5.4.5  Market Share Analysis, By Technology       

                5.5 End user                      

        5.5.1 Introduction           

        5.5.2 Private Blood Collection Centres   

        5.5.3 Public Blood Collection Centres      

        5.5.4 Hospitals  

        5.4.5 Y-o-Y Growth Analysis, By End user              

        5.4.6  Market Attractiveness Analysis, By End user           

        5.4.7  Market Share Analysis, By End user            

6. Geographical Analysis                      

                6.1 Introduction       

        6.1.1 Regional Trends    

        6.1.2 Impact Analysis     

        6.1.3 Y-o-Y Growth Analysis        

                        6.1.3.1 By Geographical Area

                        6.1.3.2 By Product

                        6.1.3.3 By Procedure

                        6.1.3.4 By Application

                        6.1.3.5 By Technology

                        6.1.3.6 By End user

        6.1.4  Market Attractiveness Analysis     

                        6.1.4.1 By Geographical Area

                        6.1.4.2 By Product

                        6.1.4.3 By Procedure

                        6.1.4.4 By Application

                        6.1.4.5 By Technology

                        6.1.4.6 By End user

        6.1.5  Market Share Analysis      

                        6.1.5.1 By Geographical Area

                        6.1.5.2 By Product

                        6.1.5.3 By Procedure

                        6.1.5.4 By Application

                        6.1.5.5 By Itechnology

                        6.1.5.6 By End user

                6.2 U.K                 

                6.3 Spain     

                6.4 Germany                     

                6.5 Italy       

                6.6 France  

7. Strategic Analysis               

                7.1 PESTLE analysis 

        7.1.1 Political     

        7.1.2 Economic 

        7.1.3 Social         

        7.1.4 Technological         

        7.1.5 Legal          

        7.1.6 Environmental       

                7.2 Porter’s Five analysis      

        7.2.1 Bargaining Power of Suppliers        

        7.2.2 Bargaining Power of Consumers    

        7.2.3 Threat of New Entrants     

        7.2.4 Threat of Substitute Products and Services              

        7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                

                8.1 Asahi Kasei Medical Co., Ltd.       

        8.1.1 Overview 

        8.1.2 Product Analysis   

        8.1.3 Financial analysis  

        8.1.4 Recent Developments       

        8.1.5 SWOT analysis       

        8.1.6 Analyst View          

                8.2 Haemonetics Corporation                    

                8.3 Terumo BCT, Inc.                      

                8.4 Fresenius Medical Care 

                8.5 Kawasumi Laboratories Inc.                 

                8.6 Cerus Corporation                   

                8.7 Hemacare Corporation  

                8.8 Kaneka Corporation                

                8.9 Braun Melsungen AG     

                8.10 Nikkiso Co., Ltd.                     

                8.11 Therakos, Inc.,

                8.12 Medica S.p.A.  

9. Competitive Landscape                   

                9.1 Market share analysis    

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures 

                9.4 New Product Launches 

10. Market Outlook and Investment Opportunities                 

Appendix                   

                a) List of Tables                

                b) List of Figures      

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Europe Apheresis Market, By Product, From 2020 to 2025 (USD Billion)
  2. Europe Devices Market, By Region, From 2020 to 2025 (USD Billion)
  3. Europe Disposables Market, By Region, From 2020 to 2025 (USD Billion)
  4. Europe Apheresis Market, By Procedure, From 2020 to 2025 (USD Billion)
  5. Europe Donor Market, By Region, From 2020 to 2025 (USD Billion)
  6. Europe Therapeutic Market, By Region, From 2020 to 2025 (USD Billion)
  7. Europe Apheresis Market, By Application, From 2020 to 2025 (USD Billion)
  8. Europe Renal Diseases Market, By Region, From 2020 to 2025 (USD Billion)
  9. Europe Neurology Market, By Region, From 2020 to 2025 (USD Billion)
  10. Europe Cancer Market, By Region, From 2020 to 2025 (USD Billion)
  11. Europe Hematology Market, By Region, From 2020 to 2025 (USD Billion)
  12. Europe Autoimmune Diseases  Market, By Region, From 2020 to 2025 (USD Billion)
  13. Europe Cardiovascular Diseases Market, By Region, From 2020 to 2025 (USD Billion)
  14. Europe Apheresis Market, By Technology, From 2020 to 2025 (USD Billion)
  15. Europe Centrifuge separation Market, By Region, From 2020 to 2025 (USD Billion)
  16. Europe Membrane Separation Market, By Region, From 2020 to 2025 (USD Billion)
  17. Europe Apheresis Market, By End user, From 2020 to 2025 (USD Billion)
  18. Europe Private Blood Collection Centres Market, By Region, From 2020 to 2025 (USD Billion)
  19. Europe Public Blood Collection Centres Market, By Region, From 2020 to 2025 (USD Billion)
  20. Europe Hospitals Market, By Region, From 2020 to 2025 (USD Billion)
  21. U.K. Apheresis Market, By Product, From 2020 to 2025 (USD Billion)
  22. U.K. Apheresis Market, By Procedure, From 2020 to 2025 (USD Billion)
  23. U.K. Apheresis Market, By Application, From 2020 to 2025 (USD Billion)
  24. U.K. Apheresis Market, By Technology, From 2020 to 2025 (USD Billion)
  25. U.K. Apheresis Market, By End user, From 2020 to 2025 (USD Billion)
  26. Germany Apheresis Market, By Product, From 2020 to 2025 (USD Billion)
  27. Germany Apheresis Market, By Procedure, From 2020 to 2025 (USD Billion)
  28. Germany Apheresis Market, By Application, From 2020 to 2025 (USD Billion)
  29. Germany Apheresis Market, By Technology, From 2020 to 2025 (USD Billion)
  30. Germany Apheresis Market, By End user, From 2020 to 2025 (USD Billion)
  31. France Apheresis Market, By Product, From 2020 to 2025 (USD Billion)
  32. France Apheresis Market, By Procedure, From 2020 to 2025 (USD Billion)
  33. France Apheresis Market, By Application, From 2020 to 2025 (USD Billion)
  34. France Apheresis Market, By Technology, From 2020 to 2025 (USD Billion)
  35. France Apheresis Market, By End user, From 2020 to 2025 (USD Billion)
  36. Italy Apheresis Market, By Product, From 2020 to 2025 (USD Billion)
  37. Italy Apheresis Market, By Procedure, From 2020 to 2025 (USD Billion)
  38. Italy Apheresis Market, By Application, From 2020 to 2025 (USD Billion)
  39. Italy Apheresis Market, By Technology, From 2020 to 2025 (USD Billion)
  40. Italy Apheresis Market, By End user, From 2020 to 2025 (USD Billion)
  41. Spain Apheresis Market, By Product, From 2020 to 2025 (USD Billion)
  42. Spain Apheresis Market, By Procedure, From 2020 to 2025 (USD Billion)
  43. Spain Apheresis Market, By Application, From 2020 to 2025 (USD Billion)
  44. Spain Apheresis Market, By Technology, From 2020 to 2025 (USD Billion)
  45. Spain Apheresis Market, By End user, From 2020 to 2025 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample